Vetter Pharma-Fertigung GmbH & Co. KG

Planning for success.

The period from preclinical through phase III is sometimes unpredictable for new molecules. With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval. We are ready to provide cli...

Quality across the supply chain 

Commercial manufacturing of pharmaceutical and biotech drugs is a complex business today, requiring close integration of sophisticated resources and technologies to deliver top quality and solve supply chain challenges. Vetter’s decades of experience as...

Packaging matters.

At every stage of your product’s life cycle, there are many packaging questions to consider –from ensuring material compatibility to meeting the growing demand for patient-friendly systems.
Vetter can help you identify and develop the right packaging strategies f...

As a leading global CDMO, we offer comprehensive fill-and-finish services from clinical development to your product's market launch and beyond.

Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 

As experienced partner in injectable manufacturing, we support you every step of the way, guiding your product through development, regulatory approval, launch, market supply and life cycle management, accelerating your ability to bring new drugs to market

With the increasing drug development for novel therapeutics, a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill-and-finish solutions. And, while the stages of early drug development are challenging, Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO) is committed to addressing this challenge by offering comprehensive expert manufacturing services for clinical trials and supporting their customer products' path to commercialization. A testament to this commitment is evidenced by the success of its Skokie facility which has already contributed to bringing five new customer products to market since it began full operations in 2011, with another four expected to launch in the next months. 

We look at your project from every angle to help you find answers that work – answers that support your goals for quality, reliability, innovation, safety, and efficiency. When you partner with us, we integrate with your team to design and implement a personalized plan for success in a shifting global marketplace.

Vetter, a globally leading contract development and manufacturing organization (CDMO), achieved gold status in the renowned, independent EcoVadis sustainability ranking. With 72 points out of a maximum of 100, the pharmaceutical service provider significantly increased its score compared to the last evaluation and is now among the top five percent of all participating companies in the industry.

Delivering your product’s potential

Vetter, a globally leading contract development and manufacturing organization (CDMO), announced the commissioning of a new warehouse designed to help meet increasing customer market supply demands. 

Delivering results across the production chain

Vetter, a globally leading contract development and manufacturing organization (CDMO), has in place a comprehensive sustainability strategy that has made it a pioneer in this energy-intensive industry. 

From clinical development to commercial production

Vetter Development Service Rankweil receives manufacturing authorization

- Important milestone reached for the new site

- Additional filling capacities for early-stage clinical development

- First customer audits already completed
 

Supporting your compounds success

Winning all six core categories and three champion ratings validates Vetter as a trusted partner

- Vetter’s high-level performance further substantiates its dedicated performance in customer-critical services

- Results affirm the approach, vision, and strategy of the company’s daily work for customers

- High ranking is further affirmation of customer experiences in working with Vetter as a strong and reliable partner

Build them together with Vetter.

Succeeding in today’s global pharmaceutical and biotech markets requires flexible thinking and precise manufacturing. No matter what phase of development your injectable product is in, we have solutions that can open new doors, shorten lead times, and solve complex challenges. At Vetter, we look at your project from every angle to help you find answers that work – answers that support your goals for quality, reliability, innovation, safety,and efficiency. When you partner with us, we integrate with your team to design and implement a personalized plan for success in a shifting global marketplace.

Pharmaceutical service provider integrates sustainability goals into its corporate strategy
 

We’re a global expert in aseptic filling and packaging of injectable drug products – learn more about us.

The company’s ongoing focus on strategic execution and sustainability sealed the win. 
 

Get your product to the clinic with confidence

The shift from preclinical to clinical development is a critical step in the development of your drug product.


During this transition, you not only have to significantly upscale production of your product, but also make many strategic decisions that will lay important groundwork for your regulatory submission, commercial production of your product, and many other key components of your products life-cycle.


This eBook will help you build a plan that not only streamlines your products path to the clinic but also sets you up for long-term development and market success - starting with a proven 6-step process for filling your critical clinical batch.

Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.

We offer a wide range of packaging services and injectable delivery systems that can be tailored to your product’s specific needs and optimize end-user convenience.

The CDMO responds to the growing demand for complex fill and finish solutions.

This innovative concept is based on the central idea of fully automated decontamination of the entire cleanroom, including RABS, using hydrogen peroxide (H2O2). V-CRT®️ is a two-barrier system that minimizes the risk of contamination and offers a number of advantages over existing concepts.

Judges describe the CDMO's "exemplary management" as a role model for other medium-sized companies.

Comprehensive support for your injectable | Aseptic fill finish services at Vetter.

Bundling of competencies optimizes workflow of customer projects.

Vetter wins the 2022 CMO Leadership Awards | Statement Sr. Vice President Carsten Press

All German sites of the pharmaceutical service provider will be supplied with green electricity.

Market developments and multifaced impacts (Interview with Oskar Gold)